๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase

โœ Scribed by Tanya Meyer; LiHui Xu; Jinli Chang; Edison T. Liu; Rolf J. Craven; William G. Cance


Book ID
102861744
Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
564 KB
Volume
104
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Rak is a 54 kDa protein tyrosine kinase originally isolated from breast cancer cells and expressed in epithelial cells. It resembles the protooncogene Src structurally but lacks an aminoโ€terminal myristylation site and localizes to the nuclear and perinuclear regions of the cell. We report here that expression of Rak in 2 different breast cancer cell lines inhibits growth and causes G~1~ arrest of the cell cycle. This growth inhibition is kinaseโ€dependent but does not require the Rak SH2 or SH3 domain. Rak also binds to the pRb tumorโ€suppressor protein but inhibits growth even in cells that lack pRb. These results suggest that Rak regulates cell growth by phosphorylating perinuclear proteins and has a function that is distinct from the Srcโ€related kinase family. ยฉ 2002 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Effects of tyrosine kinase inhibitors on
โœ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr

Growth-related oncogene produced in huma
โœ Jing Li; Neil Sidell ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 355 KB

Syk, a nonreceptor type of protein tyrosine kinase widely expressed in hematopoietic cells, is a candidate suppressor gene in human breast cancer. Reduced expression of Syk protein is correlated with poor prognosis, while its overexpression can reduce the malignant phenotype of breast cancer cells.